Skip to content
Screener

Total investments at other companies

Amalgamated Financial Corp. logo
Amalgamated Financial Corp.AMAL
$5.01M+7.1%
Banner Corporation logo
Banner CorporationBANR
$9.81M-43.3%
Uranium Energy logo
Uranium EnergyUEC
$83.96M+545%
WYF
WhiteFiber, Inc.WYFI
$1M
CPR
CPRXCPRX
$27.29M+12.7%
Axos Financial logo
Axos FinancialAX
$68.09M+92.9%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFVNINoncurrent.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(In thousands, except per share data)March 31,2026September 30,2025
Total current assets$323,439$332,966
Property and equipment, net111,226102,283
Operating lease right-of-use assets70,65549,377
Investment in equity securities[1]68,08754,337
Goodwill82,19582,195
Intangible assets, net12,99613,425
Restricted cash, non-current2,1822,376
Other non-current assets[1]5,4344,902

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's total investments?
Twist Bioscience Corporation (TWST) reported total investments of $68.09M in Q1 2026.
What does total investments mean?
This metric represents the aggregate value of all non-current financial assets held by the company, including marketable securities, long-term debt instruments, and other strategic investments. It reflects the firm's allocation of excess capital into interest-bearing or appreciation-focused vehicles rather than operational assets. Monitoring this balance provides insight into the company's liquidity management strategy and its ability to deploy capital for future growth or risk mitigation.

Ask your AI about Twist Bioscience Corporation's total investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude